Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition

被引:43
|
作者
Zhu, Xuan [1 ]
Xiang, Shasha [1 ]
Feng, Xiao [1 ]
Wang, Huanhuan [2 ]
Tian, Shiyi [1 ]
Xu, Yuanyuan [1 ]
Shi, Lihua [1 ]
Yang, Lu [2 ]
Li, Mian [3 ]
Shen, Yubiao [4 ]
Chen, Jie [1 ]
Chen, Yuewen [1 ]
Han, Jianzhong [1 ]
机构
[1] Zhejiang Gongshang Univ, Sch Food Sci & Bioengn, 18 Xuezheng St, Hangzhou 310018, Zhejiang, Peoples R China
[2] Hangzhou Normal Univ, Sch Med, Hangzhou 310018, Zhejiang, Peoples R China
[3] Zhejiang Huakang Pharmaceut Co Ltd, Quzhou 324302, Zhejiang, Peoples R China
[4] Tsinghua Univ, Yangtze Delta Reg Inst, Jiaxing 314000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cyanocobalamin; methylcobalamin; gut microbiome; inflammatory bowel disease; Enterobacteriaceae; VITAMIN-B-12; GUT; COLITIS; PATHOGENESIS; DEFICIENCY;
D O I
10.1021/acs.jafc.8b05730
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Patients with inflammatory bowel disease (IBD) are usually advised to supplement various types of vitamin B-12, because vitamin B-12 is generally absorbed in the colon. Thus, in the current study, the influence of cyanocobalamin (CNCBL) or methylcobalamin (MECBL) ingestion on IBD symptoms will be investigated. Then, whether and how the application of various cobalamins would modify the taxonomic and functional composition of the gut microbiome in mice will be examined carefully. Dextran-sulfate-sodium-induced IBD mice were treated with MECBL or CNCBL; disease activity index (DAI) scores and intestinal inflammatory conditions of mice were evaluated. Fecal samples were collected; microbiota composition was determined with a 16s rRNA analysis; functional profiles were predicted by phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt); and short-chain fatty acids were measured. The consequence of higher relative abundances of Enterobacteriaceae and isomeric short-chain fatty acids by cobalamin treatment revealed that a high concentration of CNCBL but not MECBL supplementation obviously aggravated IBD. A microbial ecosystem rich in Escherichia/Shigella and low in Lactobacillus, Blautia, and Clostridium XVIII was observed in IBD mice after a high concentration of CNCBL supplementation. In cobalamin-dependent enzymes, CNCBL was more efficient in the adenosylcobalamin system than MECBL and vice versa in the MECBL system. The distinct effects of various cobalamins were associated with the distribution and efficiency of vitamin-B-12-dependent riboswitches. CNCBL had a strong inhibitory effect on all riboswitches, especially on btuB and pocR riboswitches from Enterobacteriaceae. CNCBL aggravated IBD via enhancing the proportion of Enterobacteriaceae organisms through riboswitch and enzyme systems. The present study provides a critical reference for offering a suitable amount and type of cobalamin during a symbiotic condition.
引用
收藏
页码:916 / 926
页数:11
相关论文
共 50 条
  • [21] The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease
    Kanauchi, Osamu
    Mitsuyama, Keiichi
    Andoh, Akira
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) : 2074 - 2086
  • [22] EXAMINING THE ROLE OF AIR QUALITY ON INTESTINAL MICROBIOTA AND ITS ASSOCIATED IMPACT ON INFLAMMATORY BOWEL DISEASE
    Park, Angela
    Singh, Sirtaj
    Wang, Peiqi
    Melia, Joanna
    Parian, Alyssa
    Chowdhury, Reezwana
    Mueller, Noel
    Hutfless, Susan M.
    GASTROENTEROLOGY, 2018, 154 (06) : S603 - S604
  • [23] IgA coating of intestinal microbiota is associated with inflammatory bowel disease in twin pairs discordant for inflammatory bowel disease
    Brand, E.
    Laenen, Y.
    van Wijk, F.
    de Zoete, M.
    Oldenburg, B.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S010 - S011
  • [24] IMMUNOGLOBULIN A COATING OF INTESTINAL MICROBIOTA IS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE IN TWIN PAIRS DISCORDANT FOR INFLAMMATORY BOWEL DISEASE
    Brand, Eelco C.
    Laenen, Yaro
    van Wijk, Femke
    de Zoete, Marcel R.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2020, 158 (06) : S148 - S148
  • [25] INTESTINAL MICROBIOTA AND INFLAMMATORY BOWEL DISEASES
    Ciocoiu, Manuela
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (01): : 5 - 13
  • [26] Intestinal microbiota and inflammatory bowel diseases
    Eun, Chang Soo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (09): : 588 - 595
  • [27] The Intestinal Microbiota in Inflammatory Bowel Diseases
    Sartor, R. Balfour
    NUTRITION, GUT MICROBIOTA AND IMMUNITY: THERAPEUTIC TARGETS FOR IBD, 2014, 79 : 29 - 39
  • [28] The intestinal microbiota in inflammatory bowel diseases
    Misselwitz, Benjamin
    Haller, Dirk
    INNERE MEDIZIN, 2025, 66 (02): : 146 - 155
  • [29] Alterations in Composition and Diversity of the Intestinal Microbiota in Korean Inflammatory Bowel Diseases Patients
    Eun, Chang Soo
    Han, Dong Soo
    Lee, A. Reum
    Kim, Sun Min
    Ro, Youngouk
    Yoo, Kyo-Sang
    GASTROENTEROLOGY, 2014, 146 (05) : S444 - S444
  • [30] Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease
    Yue, Bei
    Yu, Zhi-Lun
    Lv, Cheng
    Geng, Xiao-Long
    Wang, Zheng-Tao
    Dou, Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4378 - 4393